Loading...
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Up to 50% of patients with uveal melanoma develop metastatic disease with poor prognosis. Regional, mainly liver-directed, therapies may induce limited tumor responses but do not improve overall survival. Response rates of metastatic uveal melanoma (MUM) to systemic chemotherapy are poor. Insights i...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Blackwell Science Inc
2013
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3892799/ https://ncbi.nlm.nih.gov/pubmed/24403233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|